on 16 Jun 2020
Last Applicant/ Owned by
3 rue des Frères Lumière
Jacou
FR
34830
Serial Number
88404466 filed on 26th Apr 2019
Registration Number
6077768 registered on 16th Jun 2020
Correspondent Address
Stephen P. McNamara
Filing Basis
No Filing Basis
Disclaimer
NO DATA
The color(s) black and blue is/are claimed as a feature of the mark. The mark consists of the word "MedinCell" in black letters with a blue design consisting of two horizontally oriented conjoined semi-circles located above the word "Cell" with a single vertically oriented semi-circle conjoined to the right of the two horizontally oriented conjoined semi-circles. Pharmaceutical preparations and Read More
Pharmaceutical preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical preparations, namely, a drug delivery system comprising pharmaceutical compositions for subcutaneous or intraarticular administration for the continuous release of therapeutic agents for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations, namely, a drug delivery system comprising compositions that facilitate continuous release delivery of a wide variety of therapeutic subcutaneous or intraarticular veterinary agents; pharmaceutical compositions for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate controlled release delivery of subcutaneous or intraarticular active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of drug delivery compounds that facilitate sustained or extended release of the active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate delivery of injectable pharmaceutical and veterinary pharmaceutical preparations; sustained or extended release drug delivery agents being compounds used to facilitate delivery of drugs, sold as an integral component of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; chemical preparations for medical or pharmaceutical use for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; Carriers and mediums being drug delivery agents comprised of compounds for facilitating the delivery of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical and veterinary pharmaceutical preparations and substances for subcutaneous delivery for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders
No 88404466
No Service/Collective Mark
No 07626-T0002A
No
No
No
No
No
No
No
No
26.01.06 -
Semi-circles
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of the word "MedinCell" in black letters with a blue design consisting of two horizontally oriented conjoined semi-circles located above the word "Cell" with a single vertically oriented semi-circle conjoined to the right of the two horizontally oriented conjoined semi-circles.
| Status Date | Action Taken |
|---|---|
| 16th Jun 2020 | REGISTERED-PRINCIPAL REGISTER |
| 31st Mar 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 31st Mar 2020 | PUBLISHED FOR OPPOSITION |
| 11th Mar 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 27th Feb 2020 | ELECTRONIC RECORD REVIEW COMPLETE |
| 07th Feb 2020 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 31st Jan 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 31st Jan 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 31st Jan 2020 | EXAMINERS AMENDMENT E-MAILED |
| 31st Jan 2020 | EXAMINER'S AMENDMENT ENTERED |
